PRA: 15-12G/A · amendment
ProAssurance Corporation filed Amendment No. 1 to its Form 15 to correct a technical omission. The amendment's sole purpose is to add check boxes that were inadvertently left out of the initial Form 15 filed on July 6, 2026. The underlying Form 15 relates to the suspension of the company's duty to file reports under the Securities Exchange Act of 1934. Secretary David McHale signed the administrative correction on behalf of the company on July 8, 2026.
PRA: 15-12G · other
ProAssurance Corporation has filed a Form 15 to terminate its registration of securities under Section 12(g) of the Securities Exchange Act of 1934. This action suspends the company's duty to file periodic reports, including Forms 10-K and 10-Q, with the Securities and Exchange Commission. The filing indicates that the approximate number of holders of record of the class of securities covered by the notice is 1. This reduction in shareholders indicates that the company has fallen below the threshold required to maintain public reporting status or has completed a transaction to take the company private. Consequently, ProAssurance will no longer be subject to the public reporting requirements of the Exchange Act. This event marks the end of the company's tenure as a publicly traded entity, with significant implications for liquidity and information availability for remaining investors.
PRA: S-3/A · amendment
ProAssurance Corporation filed a post-effective amendment to its Form S-3 registration statement to deregister all unsold securities following the completion of its acquisition by The Doctors Company. The merger closed on June 26, 2026, pursuant to an agreement dated March 19, 2025, with ProAssurance continuing as the surviving corporation and a wholly owned subsidiary of The Doctors Company. This filing formally terminates all offerings of the Company's securities pursuant to the original registration statement and removes the remaining unsold securities from registration.
The Doctors Company Completes Acquisition of ProAssurance Corporation
The Doctors Company has completed its acquisition of ProAssurance Corporation for $25.00 per share in cash, valuing the transaction at approximately $1.3 billion. Following the closing, ProAssurance shares have been delisted from the NYSE and deregistered with the SEC, ending public trading. ProAssurance will operate as a wholly owned subsidiary, combining to form an entity with $12 billion in assets covering over 200,000 healthcare professionals.
NETSTREIT Set to Join S&P SmallCap 600
NETSTREIT Corp. will be added to the S&P SmallCap 600 effective prior to the market open on June 29, 2026. The addition replaces ProAssurance Corp., which is being removed from the index following its pending acquisition by The Doctors Company. Inclusion in the widely tracked benchmark is expected to drive passive fund inflows and enhance liquidity for NTST shares.
PRA: 8-K · acquisition merger
ProAssurance Corporation announced that The Doctors Company has received approval from all necessary insurance regulators for their previously announced merger. This fulfills the final regulatory requirement for the transaction to proceed. With all required approvals in hand, the closing of the merger is now expected to occur on June 26, 2026. The completion of the deal remains subject only to the satisfaction of customary closing conditions.
ProAssurance Corporation reported significant progress in its pending acquisition by The Doctors Company, noting that final regulatory approvals have been received in Alabama, the District of Columbia, Illinois, Missouri, Pennsylvania, Texas, and Vermont. The company also confirmed it has obtained final approval from Lloyd’s of London and the Cayman Islands Monetary Authority for its licensed entities, leaving only the review by California insurance regulators pending. Despite the uncertainty surrounding the timing of the California review, ProAssurance continues to anticipate closing the transaction by June 30, 2026, having previously secured stockholder approval and FTC clearance.
ProAssurance Reports Results for First Quarter 2026
ProAssurance returned to profitability in the first quarter of 2026 with net income of $8.5 million, or $0.16 per share, compared to a net loss of $5.8 million in the prior year. The company's Non-GAAP combined ratio improved 2.3 points to 109.9%, driven by favorable prior year reserve development, though net premiums written decreased 6.3% to $258.6 million. Management reaffirmed its expectation to close the merger with The Doctors Company by June 30, 2026, noting that regulatory approvals have been secured in six jurisdictions while reviews remain pending in California and Pennsylvania.
